Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis

Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected patients by synthesizing several inflammatory mediators, including cytokines that initiate intracellular signaling. Recently, small molecule inhibitors of transduction and transcription signals that influence the intracellular pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutolo, Maurizio, Meroni, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890964/
https://www.ncbi.nlm.nih.gov/pubmed/24453498
http://dx.doi.org/10.2147/JIR.S35901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890964/
https://www.ncbi.nlm.nih.gov/pubmed/24453498
http://dx.doi.org/10.2147/JIR.S35901

Ejemplares similares